Recall
FDAHealthMarch 4, 2025

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distrib

⚠️ Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 4, 2025

Nationwide in the USA

What's affected?

Product
Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.
Lot code
T05393

Additional details

Lot# T05393, Exp. Date: 09/30/2025

What should I do?

Recommended action

Class III recall. Voluntary: Firm initiated Quantity affected: 224 cartons.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.